Medications

New insight into old IBD drug could improve treatments

Although it is one of the oldest medications used to treat patients with inflammatory bowel disease (IBD) and an effective treatment for an associated arthritis condition called spondyloarthritis (SpA), sulfasalazine's mechanism ...

Oncology & Cancer

Stemming colorectal cancer in Latin America

Little is known about colorectal cancer screening strategies throughout the Western Hemisphere, with the exception of the U.S. and Canada. In a recent study by Regenstrief Institute, Indiana University School of Medicine, ...

Medications

New model identifies drugs that shouldn't be taken together

Any drug that is taken orally must pass through the lining of the digestive tract. Transporter proteins found on cells that line the GI tract help with this process, but for many drugs, it's not known which of those transporters ...

Diseases, Conditions, Syndromes

Revealing the gut's crucial role in lung disease

Research led by the Centenary Institute, the University of Technology Sydney, and the Hunter Medical Research Institute suggests that the gut microbiome plays a pivotal role in the development of chronic obstructive pulmonary ...

Diseases, Conditions, Syndromes

FDA approves Eohilia for eosinophilic esophagitis

The U.S. Food and Drug Administration has approved Takeda's Eohilia (budesonide oral suspension) as the first and only oral treatment for eosinophilic esophagitis (EoE).

Diseases, Conditions, Syndromes

Discovery provides new insight into severe liver disease

Primary sclerosing cholangitis (PSC) is a severe and chronic liver disease. It affects men more than women, and most people who are diagnosed with PSC are between 30 and 40 years old.

page 41 from 237